Pharmacometrics: Support Early Decision-Making

Pharmacometrics: Support Early Decision-Making

Quantitative Insights to Inform Key Development Decisions

Book a Call with our Expert Pharmacometricians

Start Strong: Implement Pharmacometrics Early-On

The decisions drug developers make early in the development process are critical because they impact the success or failure of the drug later on. Incorporating pharmacometrics methods early in development helps quantify interactions between drugs and patients, optimizing drug development.

Global Leaders in Pharmacometrics, with a Proven Record of Success

120+

Pharmacometrics consultants over 5 continents

15+

Dedicated PKPD programmers

70+

Clinical pharmacologists, Early drug development, DMPK, CMC, and toxicology experts

800+

Pharmacometrics projects completed in the last 4 years

Pharmacometrics Services for Early Drug Development

We provide a comprehensive spectrum of decision-making support and filing support, based on quantitative analysis methodologies.

Development of Pharmacometrics Strategy/Project Plan
Modeling & Simulation Analysis Plans
Population pharmacokinetic (PopPK) analysis
Biomarker PK-PD Analysis
Disease Progression Modeling

Translational PK-PD Analysis (animal to man)
Exposure-Response Analysis of Efficacy or Safety
Cardiovascular Safety Analyses (QTc)
Model-based Meta Analysis
Clinical Trial Simulations

Request a Complimentary Consultation with a Pharmacometrician

Choose Certara: World’s Most Experienced Pharmacometrics Team

With over 120+ pharmacometricians, the Certara Pharmacometrics team designs and implements model-informed drug development (MIDD) strategies for all types of drug development programs, regardless of therapeutic area, drug modality, and development phase.

Fit-for-Purpose

Our experts are skilled at navigating the complexities of each project by creating fit-for-purpose analysis approaches, aimed at addressing the key development questions. At Certara, we value innovation, and leverage strong science, deep expertise, and strategic thinking to overcome our partners’ unique challenges.

Integrated Solutions

As a part of Certara’s Drug Development Solutions family which includes a wide range of drug development service offerings, the team is uniquely positioned to help clients put the results of pharmacometrics analyses in the context of their development strategy and achieve optimal impact on decision-making. With access to CMC, DMPK, Toxicology, and Regulatory Services, every project has access to end-to-end support.

Connect with a Pharmacometrician